Allergy and Immunology · Bel Air, MD
NPI
1144271073
Since 2006
Specialty
Allergy and Immunology
Code 207K00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
2225 Old Emmorton Rd, Suite 111
Bel Air, MD, 21015
Phone (443) 987-6998
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.5M
63,253 services
Medicare patients, 2024
811
Average age 73
Drug cost, 2024
$1.1M
3,938 prescriptions
Company payments, 2025
$3,490
From 23 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Matthew P Mardiney Sr. was code J2357 (injection, omalizumab, 5 mg), 37,727 times for 75 patients. In total Matthew P Mardiney Sr. billed 63,253 services in 31 codes, and Medicare paid $1.5M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-09-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J2357 Injection, omalizumab, 5 mg | Office | 37,727 | 75 | $29.48 | $1.1M |
| 95004 Test - Miscellaneous | Office | 6,318 | 113 | $2.65 | $17K |
| 95165 Treatment - Miscellaneous | Office | 4,479 | 191 | $10.31 | $46K |
| 95115 Treatment - Miscellaneous | Office | 2,372 | 131 | $7.54 | $18K |
| 99213 Office E&M - Established | Office | 1,882 | 713 | $62.39 | $117K |
| 96372 Injection Administration | Office | 1,706 | 113 | $10.32 | $18K |
| 95024 Test - Miscellaneous | Office | 1,576 | 95 | $6.28 | $9,905 |
| 95117 Treatment - Miscellaneous | Office | 1,489 | 91 | $8.96 | $13K |
| 95012 Pulmonary | Office | 171 | 143 | $14.11 | $2,413 |
| 94010 Pulmonary Function Testing | Office | 138 | 117 | $19.64 | $2,711 |
| 99214 Office E&M - Established | Office | 134 | 107 | $87.50 | $12K |
| 99203 Office E&M - New | Office | 123 | 123 | $84.81 | $10K |
| 95018 Test - Miscellaneous | Office | 82 | 11 | $15.25 | $1,251 |
| 94726 Pulmonary Function Testing | Office | 41 | 39 | $42.76 | $1,753 |
| 94060 Pulmonary Function Testing | Office | 39 | 39 | $30.45 | $1,188 |
By year: 2022 $1.2M for 59,592 services; 2023 $1.5M for 66,484 services; 2024 $1.5M for 63,253 services.
Medicare prescription drug claims, 2024
In 2024, the drug Matthew P Mardiney Sr. prescribed most often to Medicare patients was Hydroxyzine Hcl, with 891 prescriptions and refills. In total Matthew P Mardiney Sr. wrote 3,938 Medicare prescriptions that cost $1.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxyzine Hcl Generic | 891 | 1,421 | 273 | $12K |
| Ipratropium Bromide Generic | 459 | 764 | 174 | $17K |
| Montelukast Sodium Generic | 369 | 863 | 92 | $5,811 |
| Prednisone Generic | 191 | 242 | 148 | $1,530 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 183 | 215 | 95 | $4,434 |
| Fluticasone Propionate Generic | 131 | 239 | 50 | $1,597 |
| Cefdinir Generic | 110 | 110 | 82 | $2,381 |
| Dupixent Syringe Dupilumab | 106 | 141 | 18 | $554K |
| Azelastine Hcl Generic | 98 | 182 | 45 | $3,969 |
| Triamcinolone Acetonide Generic | 78 | 127 | 57 | $975 |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 74 | 90 | 13 | $57K |
| Azithromycin Generic | 73 | 73 | 49 | $296 |
| Tramadol Hcl Generic | 63 | 63 | 13 | $201 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 59 | 71 | 11 | $45K |
| Tizanidine Hcl Generic | 49 | 77 | 21 | $421 |
Brand drugs: - claims; generic drugs: 3,183 claims; opioid claims: 63.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Matthew P Mardiney Sr. $3,490 ($3,490 in general payments such as food, travel and fees) from 23 companies. The largest payer was GlaxoSmithKline, LLC. with $413.
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. GSK | 16 | $413 |
| AstraZeneca Pharmaceuticals LP AZN | 14 | $347 |
| Abbvie Inc. ABBV | 15 | $341 |
| Novartis Pharmaceuticals Corporation NVS | 13 | $282 |
| Pfizer Inc. PFE | 16 | $272 |
| Amgen Inc. AMGN | 19 | $268 |
| Regeneron Healthcare Solutions, Inc. REGN | 9 | $258 |
| Genzyme Corporation SNY | 13 | $248 |
| Lilly USA, LLC LLY | 6 | $190 |
| Genentech USA, Inc. ROG.SW | 8 | $174 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.